H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.7% of adults in Fresno have diagnosed diabetes — 0.7 points above the U.S. 12% figure. Census population 542,107. California Medicare wound biologics: Noridian Healthcare Solutions (JE). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Fresno clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Fresno storefront.
Growth Factor Therapy for Tissue Repair in Fresno, CA for clinics & physicians. Growth factor therapy prod… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of growth factor therapy in Fresno: (1) CDC PLACES (2023, crude) estimates 12.7% of adults in Fresno have diagnosed diabetes — 0.7 points above the U.S. 12% figure. (2) California Part B wound biologics are reviewed by Noridian Healthcare Solutions under JE, shared with HI, NV. We help with the second file. We do not pretend to be a Fresno storefront.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)15.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 500k–1M with 542,107 residents will still mix those payers. CDC PLACES (2023, crude) estimates 12.7% of adults in Fresno have diagnosed diabetes — 0.7 points above the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES (2023, crude) estimates 12.7% of adults in Fresno have diagnosed diabetes — 0.7 points above the U.S. 12% figure. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the growth factor therapy account.
CDC PLACES (2023, crude prevalence) estimates 12.7% of adults — 0.7 points above the U.S. 12% figure. Obesity is 37.5%; arthritis is 21.2%. That is place-level BRFSS modeling, not a clinic census and not a Fresno trial.
This URL is written for healthcare providers shopping distribution. Patient-facing ads must follow your state medical board and FTC rules. Do not copy distributor language into consumer ads that imply guaranteed healing.
California is not in CDC’s core Diabetes Belt list, but 12% national prevalence still means diabetic wounds will appear. Stock from your clinic mix, not from belt branding.
No. Hawk Medical LLC is a national distributor founded in 2014. We ship HCT/P 361-compliant tissue, PRP systems, and wound-care biologics to physician practices nationwide, including California. There is no Fresno storefront or local street address on this page because we are a service-area distributor, not a walk-in clinic.
Bring specialty, monthly joint / regenerative volume, and whether you bill JE FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 12.7% diabetes and 21.2% arthritis for Fresno — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Fresno, CA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Fresno is JE geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Fresno — 0.7 points above the U.S. 12% figure. Planning input, not an outcomes claim.
California Part B wound biologics follow this contractor (siblings: HI, NV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Fresno. Useful for joint-program math; still needs a diagnosis and privileging.
No Fresno storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.